C. Frank Scott III - Jul 1, 2021 Form 4/A - Amendment Insider Report for BLUE RIDGE BANKSHARES, INC. (BRBS)

Role
Director
Signature
/s/ C. Frank Scott III
Stock symbol
BRBS
Transactions as of
Jul 1, 2021
Transactions value $
$25,012
Form type
4/A - Amendment
Date filed
11/2/2021, 03:05 PM
Date Of Original Report
Aug 18, 2021
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRBS Common Stock Award $25K +1.4K +0.95% $17.93 147K Jul 1, 2021 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRBS Stock Option (right to buy) 750 Jul 1, 2021 Common Stock 750 $12.00 Direct F5, F6
holding BRBS Stock Option (right to buy) 7.93K Jul 1, 2021 Common Stock 7.93K $13.80 Direct F7, F8
holding BRBS Stock Option (right to buy) 750 Jul 1, 2021 Common Stock 750 $10.77 Direct F9, F10
holding BRBS Stock Option (right to buy) 3.75K Jul 1, 2021 Common Stock 3.75K $10.80 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 reports again the reporting person's acquisition of 1,395 shares of the issuer's common stock. The original Form 4 inadvertently reported the acquisition as a disposition of stock.
F2 Stock received in lieu of cash compensation
F3 Restricted stock subject to a vesting schedule.
F4 On March 17, 2021, Blue Ridge Bankshares, Inc., (the "Company") declared a three-for-two stock split effected in the form of a 50% stock dividend on its common stock outstanding to shareholders of record as of April 20, 2021. As a result, the reporting person received 48,692 shares of the Company's common stock as of April 20, 2021.
F5 This option was previously reported as an option for 500 shares of common stock at an exercise price of $18.00, but was adjusted to reflect the stock split declared by the Company on March 17, 2021.
F6 As a result of the stock split declared by the Company on March 17, 2021, the reporting person received 250 shares of the Company's common stock as of April 20, 2021. At the same time, pursuant to anti-dilution provisions of the Company's equity compensation plans, an option for 750 shares of common stock held by the reporting person on April 20, 2021 became exercisable for 750 shares of common stock.
F7 This option was previously reported as an option for 5,289 shares of common stock at an exercise price of $20.70, but was adjusted to reflect the stock split declared by the Company on March 17, 2021.
F8 As a result of the stock split declared by the Company on March 17, 2021, the reporting person received 2,644 shares of the Company's common stock as of April 20, 2021. At the same time, pursuant to anti-dilution provisions of the Company's equity compensation plans, an option for 7,933 shares of common stock held by the reporting person on April 20, 2021 became exercisable for 7,933 shares of common stock.
F9 This option was previously reported as an option for 500 shares of common stock at an exercise price of $16.16, but was adjusted to reflect the stock split declared by the Company on March 17, 2021.
F10 As a result of the stock split declared by the Company on March 17, 2021, the reporting person received 250 shares of the Company's common stock as of April 20, 2021. At the same time, pursuant to anti-dilution provisions of the Company's equity compensation plans, an option for 750 shares of common stock held by the reporting person on April 20, 2021 became exercisable for 750 shares of common stock.
F11 This option was previously reported as an option for 2,500 shares of common stock at an exercise price of $16.20, but was adjusted to reflect the stock split declared by the Company on March 17, 2021
F12 As a result of the stock split declared by the Company on March 17, 2021, the reporting person received 1,250 shares of the Company's common stock as of April 20, 2021. At the same time, pursuant to anti-dilution provisions of the Company's equity compensation plans, an option for 3,750 shares of common stock held by the reporting person on April 20, 2021 became exercisable for 3,750 shares of common stock.